MoneyWorks4Me

Ajanta Pharma informs about issuance of duplicate share certificate

06 Sep 2021 Evaluate

Ajanta Pharma has informed pursuant to Regulation 39(3) of SEBI (Listing obligation and Disclosure Requirement) Regulation, 2015 (Listing Regulations) that the company has on 3rd September 2021 issued duplicate share certificate of the shareholder, Pushpadevi R. Agrawal (Folio No: 0000312).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..